Litigation Details for TAKEDA PHARMACEUTICAL COMPANY LTD. v. INDOCO REMEDIES LTD. (D.N.J. 2018)
✉ Email this page to a colleague
TAKEDA PHARMACEUTICAL COMPANY LTD. v. INDOCO REMEDIES LTD. (D.N.J. 2018)
Docket | ⤷ Sign Up | Date Filed | 2018-01-02 |
Court | District Court, D. New Jersey | Date Terminated | 2018-03-07 |
Cause | 15:1126 Patent Infringement | Assigned To | Stanley R. Chesler |
Jury Demand | None | Referred To | Cathy L. Waldor |
Parties | TAKEDA PHARMACEUTICALS AMERICA, INC. | ||
Patents | 7,807,689; 8,173,663; 8,288,539; 8,900,638 | ||
Attorneys | WILLIAM C. BATON | ||
Firms | Saul Ewing Arnstein & Lehr LLP | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in TAKEDA PHARMACEUTICAL COMPANY LTD. v. INDOCO REMEDIES LTD.
Details for TAKEDA PHARMACEUTICAL COMPANY LTD. v. INDOCO REMEDIES LTD. (D.N.J. 2018)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2018-01-02 | 1 | expiration of U.S. Patent Nos. 7,807,689 (“the ’689 patent”), 8,173,663 (“the ’663 patent”), 8,288,539 (“…(“the ’539 patent”), and 8,900,638 (“the ’638 patent”) (collectively, the “patents-in-suit” or the “asserted… 1. This is an action for patent infringement under the patent laws of the United States, Title… of the patents-in-suit against Indoco. THE PATENTS-IN-SUIT …United States Patent and Trademark Office (“USPTO”) duly and lawfully issued the ’689 patent entitled, “ | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |